Reaction
Vaccination Failure reporting signals
As of the last recalculation, Vaccination Failure appears in 1,649 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is BENDAMUSTINE HCL (PRR 32.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bendamustine Hcl | 39 | 32.5 | 32.6 |
| Rituximab | 408 | 32.0 | 32.1 |
| Remdesivir | 32 | 30.9 | 31.0 |
| Mycophenolate Mofetil | 226 | 24.2 | 24.2 |
| Mycophenolate Mofetil Hydrochloride | 226 | 24.1 | 24.2 |
| Human Immunoglobulin G | 32 | 19.9 | 20.0 |
| Tacrolimus Ointment 0.1% | 167 | 18.7 | 18.7 |
| Tacrolimus Extended-Release Capsules | 167 | 18.7 | 18.7 |
| Ocrelizumab | 86 | 18.4 | 18.4 |
| Tacrolimus | 184 | 16.6 | 16.6 |
| Obinutuzumab | 21 | 16.3 | 16.3 |
| Mycophenilic Acid | 25 | 15.4 | 15.5 |
| Mycophenolic Acid | 38 | 15.3 | 15.3 |
| Bendamustine Hydrochloride | 14 | 14.9 | 14.9 |
| Pyrazinamide | 10 | 13.5 | 13.5 |
| Doxorubicin | 76 | 11.2 | 11.2 |
| Baricitinib | 8 | 10.5 | 10.5 |
| Atovaquone | 6 | 9.4 | 9.4 |
| Sirolimus | 10 | 9.4 | 9.4 |
| Valacyclovir | 29 | 8.9 | 8.9 |
| Rifampicin | 7 | 8.8 | 8.8 |
| Fingolimod Hcl | 56 | 8.4 | 8.4 |
| Everolimus Tablets | 11 | 8.3 | 8.3 |
| Lamivudine Oral | 16 | 8.1 | 8.1 |
| Isoniazid | 10 | 7.8 | 7.8 |
| Vincristine Sulfate | 18 | 7.8 | 7.8 |
| Cyclophosphamide Injection, Solution | 100 | 7.5 | 7.5 |
| Cyclophosphamide | 100 | 7.5 | 7.5 |
| Cyclophosphamide For Injection | 100 | 7.5 | 7.5 |
| Mepolizumab | 29 | 7.5 | 7.5 |
| Fludarabine Phosphate | 23 | 7.5 | 7.5 |
| Eculizumab | 29 | 6.8 | 6.8 |
| Belimumab | 17 | 6.8 | 6.8 |
| Daratumumab | 18 | 5.7 | 5.7 |
| Siponimod | 3 | 4.3 | 4.3 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 6 | 4.2 | 4.2 |